3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Leukemia
2
Ventilator-Induced Lung Injury
1
Urologic Neoplasms
1
Urogenital Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Leukemia, Myeloid, Acute
1
Kidney Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
aldesleukin
22
Sunitinib
21
Bevacizumab
16
Interleukin-2
14
Everolimus
14
Interferon-alpha
13
Gemcitabine
13
Cyclophosphamide
13
fludarabine phosphate
11
Peripheral Blood Stem Cell Transplantation
9
Sorafenib
8
Filgrastim
8
Axitinib
8
Nivolumab
7
pembrolizumab
6
Ipilimumab
6
Doxorubicin
6
Carboplatin
6
sargramostim
5
cabozantinib
5
Capecitabine
5
Thalidomide
4
Tacrolimus
4
Radiotherapy
4
Radiosurgery
4
Neoadjuvant Therapy
4
Mycophenolic Acid
4
Magnetic Resonance Spectroscopy
4
Erlotinib Hydrochloride
4
Chemotherapy, Adjuvant
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Kidney Neoplasms
×
Dosage Forms
×
Clear all
NCT04644432
2020-11-25
INDIGO
Herlev and Gentofte Hospital
Phase 2
Unknown
30 enrolled